{
    "nctId": "NCT02403869",
    "briefTitle": "Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monochemotherapy",
    "officialTitle": "Study of Quality of Life in Patients With Metastatic Breast Cancer Treated With Second-line Monochemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 149,
    "primaryOutcomeMeasure": "Definitive deterioration at 6 months",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who give their written informed consent.\n* Patients with metastatic breast cancer who start treatment with second-line monochemotherapy.\n* Patients of both sexes, at least 18 years of age and of any race.\n* Patients with life expectancy longer than or equal to 12 weeks.\n* Patients with histological or cytological diagnosis of Her-2/neu negative breast adenocarcinoma.\n* Patients with ability enough to understand the questionnaires.\n\nExclusion Criteria:\n\n* Pregnant or lactating women.\n* Patients who have been treated with chemotherapy in the last three weeks\n* Patients who refuse to participate in the study.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}